Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gennaro Marco Falco
Observed names:
Falco, Gennaro Marco,
G. M. Falco,
Gennaro M Falco,
Gennaro M. FALCO,
Gennaro M. Falco
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0009-0001-1219-9008
Observed ORCID:
0009-0001-1219-9008
OpenAlex ID:
A5091484685
Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER – study)
2024
·
Diego Orsini
, Giacomo Caldarola
, et al.
·
Journal of Dermatological Treatment
·
22
PDF
Successful treatment with tralokinumab in patients with atopic dermatitis and dupilumab‐induced psoriasis
2023
·
L. Quattrini
, G. Caldarola
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
15
PDF
Anti-IL-17 monoclonal antibodies and bullous pemphigoid: treatment or causal agents? A case series and review of the literature
2024
·
Anna Paola Lugli
, Giacomo Caldarola
, et al.
·
Drugs in Context
·
7
Clinical, epidemiological, and therapeutic hallmarks of pyoderma gangrenosum: a case series of 35 patients
2024
·
Giacomo Caldarola
, Daniele O. Traini
, et al.
·
International Journal of Dermatology
·
7
PDF
Low grade of satisfaction related to the use of current systemic therapies among pustular psoriasis patients: a therapeutic unmet need to be fulfilled
2024
·
Giulia Coscarella
, Gennaro Marco Falco
, et al.
·
Frontiers in Medicine
·
7
PDF
Drug survival of biologics and non‐biologics in patients affected by palmoplantar psoriasis: a “real‐world”, mono‐center experience
2023
·
Giacomo Caldarola
, Gennaro Marco Falco
, et al.
·
International Journal of Dermatology
·
6
Residual disease is the main, but not the only factor impacting satisfaction in psoriatic patients undergoing biological therapies
2024
·
Giacomo Caldarola
, Eleonora De Luca
, et al.
·
International Journal of Dermatology
·
4
PDF
The Psoriasis–Eczema Interface: Clinical Classification and Therapeutic Implications From a Bicentric Experience
2026
·
Michela D'Agostino
, Gennaro Marco Falco
, et al.
·
International Journal of Dermatology
·
3
Superior Clinical and Economic Value of IL ‐23 Inhibitors Versus Adalimumab Biosimilars in Plaque Psoriasis
2026
·
Gennaro Marco Falco
, Elena Ippoliti
, et al.
·
International Journal of Dermatology
·
3
Eczematous Eruption During Bimekizumab Treatment in a Psoriatic Patient Previously Treated with Secukinumab
2024
·
Gennaro Marco Falco
, Giacomo Caldarola
, et al.
·
Skin Health and Disease
·
3
PDF
Switching to brodalumab after failure of IL ‐ 17A inhibitors in psoriatic patients: A real‐life multicentre study
2025
·
Riccardo Balestri
, Giulia Odorici
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
2
Long‐Term Real‐World Safety Profile of Secukinumab Assessed Through a 9‐Year Experience in Patients Affected by Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Results From a Multicentric Retrospective Study
2025
·
Elena Ippoliti
, Gennaro Marco Falco
, et al.
·
Dermatologic Therapy
·
1
PDF
Psoriasis occurrence in patients with atopic dermatitis treated with dupilumab and tralokinumab
2026
·
Luisa BOETI
, Gennaro M. FALCO
, et al.
·
Italian Journal of Dermatology and Venereology
Corrigendum to “Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology” [Digestive and Liver Disease 58 (2026) 1051-1060]
2026
·
Franco Scaldaferri
, Federica Di Vincenzo
, et al.
·
Digestive and Liver Disease
Real-life effectiveness and safety of bimekizumab in patients with moderate plaque psoriasis: a 54-week multicentre study in the Lazio region
2026
·
Francesca Feresin
, Nicoletta Bernardini
, et al.
·
Drugs in Context
PDF
Innovation and sustainability in immune-mediated diseases: An Italian multidisciplinary consensus across gastroenterology, dermatology, and rheumatology
2026
·
Franco Scaldaferri
, Federica Di Vincenzo
, et al.
·
Digestive and Liver Disease
PDF
CORONATE: A Novel Questionnaire to Assess the Long-Term Impact of Psoriasis on Patients’ Lives
2026
·
Stefano Piaserico
, Francesca Sampogna
, et al.
·
Dermatology Practical & Conceptual
No Increased Risk of Thromboembolic Events During 6‐Month Treatment With Baricitinib in Patients With Alopecia Areata
2025
·
Giacomo Caldarola
, Antonietta Ferretti
, et al.
·
International Journal of Dermatology
PDF
Supplementary material related to the manuscript submitted to the International Journal of Dermatology
2025
·
Caldarola, Giacomo
, Ferretti, Antonietta
, et al.
·
Mendeley Data
Efficacy of Dupilumab in a Young Woman with Refractory Cutaneous Lichen Planus: A Case-Based Review
2025
·
Cristina Guerriero
, Luisa Boeti
, et al.
·
Diseases
Journey of Patients with Psoriasis in an Italian Tertiary Centre, an 11-year Retrospective Analysis
2025
·
Elena Ippoliti
, Gennaro Marco Falco
, et al.
·
Acta Dermato Venereologica
PDF
Paradoxe Hautreaktion auf Certolizumab mit Überlappung neutrophiler Dermatosen
2024
·
Laura Calabrese
, Gennaro Marco Falco
, et al.
·
JDDG Journal der Deutschen Dermatologischen Gesellschaft
Paradoxical skin reaction to certolizumab, an overlap of neutrophilic dermatoses
2024
·
Laura Calabrese
, Gennaro Marco Falco
, et al.
·
JDDG Journal der Deutschen Dermatologischen Gesellschaft
PDF
Show more works
View as search
Works count:
23
Citation count:
80
H-index:
6
I10-index:
2
Year
Topic
Type